Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DCL000624

Drug Information
NameRidaforolimus    
SynonymsAP-23573; AP 23573; Deforolimus; S1022_Selleck; Ridaforolimus; MK 8669; MK-8669; 572924-54-0; AP23573, MK-8669, Ridaforolimus, Deforolimus    
CompanyMerck    
IndicationCancer; SarcomaPhase III    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
CAS NumberCAS 572924-54-0
Formular C53H84NO14P    
PubChem Compound IDCID 11520894.    
PubChem Substance IDSID 16622718.    
ClinicalTrials.govNCT00538239;    
TargetSerine/threonine-protein kinase mTOR Inhibitor[1][2]
Ref 1Merck. Product Development Pipeline. July 15 2009. To Reference
Ref 2Merck. Report of Merck. January 20 2008. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543